Literature DB >> 33052391

Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?

Harald Schmidt1, Lawrence O Gostin2, Michelle A Williams3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33052391     DOI： 10.1001/jama.2020.20571

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  23 in total

1.  COUNTERPOINT: Is Considering Social Determinants of Health Ethically Permissible for Fair Allocation of Critical Care Resources During the COVID-19 Pandemic? No.

Authors:  John L Hick; Dan Hanfling
Journal:  Chest       Date:  2022-07       Impact factor: 10.262

2.  POINT: Is Considering Social Determinants of Health Ethically Permissible for Fair Allocation of Critical Care Resources During the COVID-19 Pandemic? Yes.

Authors:  Douglas B White; Bernard Lo; Monica E Peek
Journal:  Chest       Date:  2022-07       Impact factor: 10.262

3.  Diversifying Recruitment Registries: Considering Neighborhood Health Metrics.

Authors:  J D Grill; A Kind; D Hoang; D L Gillen
Journal:  J Prev Alzheimers Dis       Date:  2022

4.  Health Communication and Decision Making about Vaccine Clinical Trials during a Pandemic.

Authors:  Aisha T Langford
Journal:  J Health Commun       Date:  2020-10-02

Review 5.  Body mass index is just a number: Conflating riskiness and unhealthiness in discourse on body size.

Authors:  Iliya Gutin
Journal:  Sociol Health Illn       Date:  2021-06-04

6.  Economic lessons for COVID-19 pandemic policies.

Authors:  W Kip Viscusi
Journal:  South Econ J       Date:  2021-03-04

7.  Addressing Justified Vaccine Hesitancy in the Black Community.

Authors:  Cato T Laurencin
Journal:  J Racial Ethn Health Disparities       Date:  2021-03-30

8.  Mitigating Inequities and Saving Lives with ICU Triage during the COVID-19 Pandemic.

Authors:  Douglas B White; Bernard Lo
Journal:  Am J Respir Crit Care Med       Date:  2021-02-01       Impact factor: 21.405

9.  Race, Ethnicity, Neighborhood Characteristics, and In-Hospital Coronavirus Disease-2019 Mortality.

Authors:  Jianhui Hu; Christie M Bartels; Richard A Rovin; Laura E Lamb; Amy J H Kind; David R Nerenz
Journal:  Med Care       Date:  2021-10-01       Impact factor: 3.178

10.  Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic.

Authors:  J Ryan Bariola; Erin K McCreary; Tina Khadem; Graham M Snyder; Richard J Wadas; David A Nace; Douglas B White; Donald M Yealy; Mark Schmidhofer
Journal:  Open Forum Infect Dis       Date:  2021-03-26       Impact factor: 3.835
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.